Brentview Investment Management LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 10,801 shares of the healthcare conglomerate’s stock, valued at approximately $5,464,000. UnitedHealth Group makes up 3.1% of Brentview Investment Management LLC’s holdings, making the stock its 8th largest holding.
A number of other institutional investors have also bought and sold shares of the business. Catalina Capital Group LLC grew its position in shares of UnitedHealth Group by 1.5% during the fourth quarter. Catalina Capital Group LLC now owns 4,034 shares of the healthcare conglomerate’s stock valued at $2,041,000 after purchasing an additional 60 shares in the last quarter. Princeton Global Asset Management LLC grew its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. Princeton Global Asset Management LLC now owns 23,351 shares of the healthcare conglomerate’s stock valued at $11,812,000 after purchasing an additional 183 shares in the last quarter. Oregon Pacific Wealth Management LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at about $424,000. Means Investment CO. Inc. grew its position in shares of UnitedHealth Group by 5.7% during the fourth quarter. Means Investment CO. Inc. now owns 4,862 shares of the healthcare conglomerate’s stock valued at $2,459,000 after purchasing an additional 262 shares in the last quarter. Finally, Abner Herrman & Brock LLC grew its position in shares of UnitedHealth Group by 3.1% during the fourth quarter. Abner Herrman & Brock LLC now owns 24,412 shares of the healthcare conglomerate’s stock valued at $12,349,000 after purchasing an additional 737 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.
UnitedHealth Group Stock Down 0.6 %
UnitedHealth Group stock opened at $542.30 on Monday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a fifty day moving average of $536.17 and a two-hundred day moving average of $565.26. The firm has a market cap of $499.07 billion, a P/E ratio of 34.99, a P/E/G ratio of 1.48 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s dividend payout ratio is presently 54.19%.
Analysts Set New Price Targets
UNH has been the subject of several recent research reports. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. KeyCorp reiterated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. Barclays decreased their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Finally, Bank of America decreased their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a research note on Wednesday, October 16th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $629.32.
Read Our Latest Stock Analysis on UnitedHealth Group
Insider Buying and Selling
In related news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.33% of the stock is owned by company insiders.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- 3 Warren Buffett Stocks to Buy Now
- 3 Underrated Robotics Stocks Poised for Major Growth
- Consumer Discretionary Stocks Explained
- Reshoring Riches: Investing in Made in America 2.0
- What is the Hang Seng index?
- 3 REITs to Watch as Interest Rates Keep Falling
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.